(ARQT) - Analyst Ratings

(ARQT) – Analyst Ratings

Feb 28, 2024 03:31 AM Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $11 at Goldman Sachs, 'Zoryve launches trending positively'
Jan 3, 2024 01:01 AM Mizuho Securities Upgrades Arcutis Biotherapeutics Inc. (ARQT) to Buy
Jan 2, 2024 04:08 PM
Nov 7, 2023 04:07 PM
Oct 26, 2023 04:47 AM
Oct 13, 2023 03:16 AM
Feb 8, 2023 12:25 PM
Sep 26, 2022 10:03 AM
Sep 21, 2022 04:43 PM
Sep 7, 2022 05:59 AM
Jul 7, 2022 06:15 AM
Jun 28, 2022 06:05 AM
Jun 6, 2022 08:41 AM
May 25, 2022 02:33 PM
May 6, 2022 05:58 AM
Apr 7, 2022 06:17 AM
Mar 29, 2022 05:54 AM
Mar 28, 2022 10:28 AM
Mar 23, 2022 06:05 AM
Mar 17, 2022 06:04 AM
Feb 23, 2022 05:45 AM
Feb 1, 2022 11:31 AM
Jan 20, 2022 04:21 PM
Jan 18, 2022 06:13 AM
Jun 29, 2021 04:06 PM
May 27, 2021 04:24 AM
Feb 1, 2021 09:46 AM
Jan 28, 2021 07:57 AM
Nov 9, 2020 04:43 AM
Oct 8, 2020 06:16 AM
Jul 30, 2020 06:47 AM
Jul 29, 2020 08:37 AM
Jul 28, 2020 06:52 AM
Feb 25, 2020 06:54 AM
Feb 25, 2020 05:45 AM
Feb 25, 2020 04:38 AM
Feb 25, 2020 04:38 AM